What Promea Therapeutics does
Founded in 2017, Promea Therapeutics operates in Health Tech offering exceptional Life Science products and cutting-edge diagnostics. The company specialises in Clinical Chemistry Immunodiagnostics, Molecular Diagnostics, and Infusion Therapies, supported by a team of dedicated R&D experts. Their commitment to precision and quality drives the development of innovative kits and devices manufactured in state-of-the-art facilities. Promea prioritises customer satisfaction as a guiding principle in its operations, reflecting a strong ethos of excellence.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Promea Therapeutics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.